IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $399,000 | +24.3% | 20,511 | +6.4% | 0.01% | +28.6% |
| Q4 2017 | $321,000 | -16.0% | 19,276 | +2.4% | 0.01% | -22.2% |
| Q3 2017 | $382,000 | +30.4% | 18,821 | +3.6% | 0.01% | +28.6% |
| Q2 2017 | $293,000 | +34.4% | 18,175 | +5.4% | 0.01% | +16.7% |
| Q1 2017 | $218,000 | +1.9% | 17,245 | +6.8% | 0.01% | 0.0% |
| Q4 2016 | $214,000 | -40.6% | 16,144 | +6.2% | 0.01% | -40.0% |
| Q3 2016 | $360,000 | -7.9% | 15,205 | +12.1% | 0.01% | -9.1% |
| Q2 2016 | $391,000 | +0.8% | 13,564 | +11.8% | 0.01% | -8.3% |
| Q1 2016 | $388,000 | -15.1% | 12,132 | +13.6% | 0.01% | -14.3% |
| Q4 2015 | $457,000 | +29.5% | 10,683 | +6.7% | 0.01% | +16.7% |
| Q3 2015 | $353,000 | -16.5% | 10,013 | +8.7% | 0.01% | -7.7% |
| Q2 2015 | $423,000 | +2.4% | 9,211 | +4.6% | 0.01% | 0.0% |
| Q1 2015 | $413,000 | +53.0% | 8,808 | +3.3% | 0.01% | +550.0% |
| Q4 2014 | $270,000 | +38.5% | 8,524 | +3.9% | 0.00% | 0.0% |
| Q3 2014 | $195,000 | -20.7% | 8,205 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $246,000 | +17.7% | 8,190 | +3.4% | 0.00% | 0.0% |
| Q1 2014 | $209,000 | -19.3% | 7,921 | -23.0% | 0.00% | 0.0% |
| Q4 2013 | $259,000 | +34.2% | 10,289 | +9.3% | 0.00% | 0.0% |
| Q3 2013 | $193,000 | +7.2% | 9,416 | +4.4% | 0.00% | 0.0% |
| Q2 2013 | $180,000 | – | 9,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |